Definitive Healthcare Corp.
$1.05
▼
-0.92%
2026-04-21 06:25:01
www.definitivehc.com
NMS: DH
Explore Definitive Healthcare Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$147.1 M
Current Price
$1.05
52W High / Low
$4.7 / $0.92
Stock P/E
—
Book Value
$2.7
Dividend Yield
—
ROCE
-3.56%
ROE
-40.42%
Face Value
—
EPS
$-1.3
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
678
Beta
1.6
Debt / Equity
45.56
Current Ratio
1.64
Quick Ratio
1.64
Forward P/E
4.99
Price / Sales
0.41
Enterprise Value
$188.42 M
EV / EBITDA
5.3
EV / Revenue
0.78
Rating
Hold
Target Price
$2.49
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 2. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
| 3. | SCWorx Corp. | $1.05 | — | $1.18 M | — | -27.93% | -76.35% | $13.05 / $0.76 | $0.52 |
| 4. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 5. | HealthEquity, Inc. | $83.22 | 33.83 | $7.04 B | — | 10.16% | 10.19% | $116.65 / $72.76 | $24.79 |
| 6. | Forian Inc. | $2.16 | — | $67.1 M | — | -8.29% | -9.61% | $2.71 / $1.64 | $0.96 |
| 7. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 61.53 M | 60.05 M | 60.75 M | 59.19 M | 62.29 M |
| Operating Profit | -6.71 M | -3.38 M | -3.5 M | -6.99 M | 0.33 M |
| Net Profit | -9.31 M | -14.84 M | -7.55 M | -107.23 M | -59.08 M |
| EPS in Rs | -0.09 | -0.14 | -0.07 | -1.03 | -0.57 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 241.52 M | 252.2 M | 251.41 M | 222.65 M |
| Operating Profit | -20.58 M | -9.74 M | -30.91 M | -36.15 M |
| Net Profit | -138.93 M | -413.12 M | -202.39 M | -7.22 M |
| EPS in Rs | -1.33 | -3.95 | -1.94 | -0.07 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 735.49 M | 1.09 B | 1.83 B | 2.12 B |
| Total Liabilities | 356.5 M | 482.19 M | 626.73 M | 640.68 M |
| Equity | 281.11 M | 444.38 M | 861.36 M | 948.92 M |
| Current Assets | 257.61 M | 370.17 M | 393.93 M | 413.75 M |
| Current Liabilities | 156.79 M | 161.16 M | 170.68 M | 140.61 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 53.78 M | 58.2 M | 41.19 M | 35.58 M |
| Investing CF | 153.88 M | -26.41 M | -31.78 M | -248.9 M |
| Financing CF | -150.79 M | -56.75 M | -25.58 M | -26.7 M |
| Free CF | 37.06 M | 45.85 M | 38.21 M | 27.25 M |
| Capex | -16.72 M | -12.34 M | -2.98 M | -8.33 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.31% | 12.92% | — | — |
| Earnings Growth % | -104.12% | -2702.38% | — | — |
| Profit Margin % | -163.81% | -80.5% | -3.24% | — |
| Operating Margin % | -3.86% | -12.29% | -16.24% | — |
| Gross Margin % | 78.3% | 81.11% | 80.86% | — |
| EBITDA Margin % | -224.92% | -95.95% | 11.78% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.